News Center

Home page

Peak Report

News reports

Solidly promote the "three drop three improve" and vigorously carry out technical research

Release time:

2020-08-14

Solidly Pushing Forward "Three Decreases and Three Improves" Vigorously Carrying out Technical Research

Group Company 2017 Advanced Enterprise Pharmaceutical Company Jinxi Pharmaceutical Factory

Review 2017 , Jinxi Factory received nearly 100 visits and exchanges, through many surprise inspections and drug sampling inspections by drug supervision, safety supervision, environmental protection, and fire protection departments, the normal supply of various products has been guaranteed under the circumstances of stricter supervision and tight supply. In the case of a significant increase in raw and auxiliary packaging materials and labor costs, the cost of the preparation is saved 625 . The sharp drop in production costs is mainly due to the solid advancement of the "three reductions and three improvements" work and the vigorous development of technical research projects.

2017 , the whole factory completed a total of "three reductions and three improvements" measures 75 , covering energy, materials and labor costs. In terms of electricity consumption, after the implementation of all measures, Jinxi Factory will save electricity 100 degrees per year, accounting for 10% of the annual electricity consumption. The renovation of the blower in the sewage station saves electricity 5 degrees / years; After the renovation of the laboratory refrigeration system, electricity can be saved 70560 degrees every summer. However, the power center and the preparation workshop can save basic electricity charges 7.68 yuan and 5.12 yuan respectively through the overall arrangement of steam, only by reporting 24 hours, the basic cost 1400 yuan can be saved. The negotiated change of the liquid hazardous waste disposal unit can not only realize the exemption of hazardous waste transportation and disposal fees, but also charge part of the solvent transfer fee, which can save the cost of 26 yuan / years based on the annual disposal of liquid waste 73 tons. The decrease in the cost of raw materials used in

formulations is closely related to the increase in solvent recovery and technical research efforts in the raw material workshop. The solution to the problem of insoluble particles in methyl oxime raw materials has realized the continuous production of products. Through the adjustment and transformation of multiple processes, the yield has increased by 13% , and the cost per batch has decreased by 1.4 yuan. Paroxetine hydrochloride and amlodipine aspartate have carried out six technical research at the same time, greatly saving the cost of raw materials.

2017 , although the number of people in Jinxi Factory did not decrease significantly, under the condition that the employment gap reached 20% , it not only ensured the normal supply of its own products, but also digested the 2000 jobs required for the centralized operation of new products and contract manufacturing business, it also solved the problem of serious labor shortage when half of the site QA took maternity leave and the three lines of the raw material workshop were opened at the same time, thanks to the compression and allocation of labor in QA and the workshop.

2017 Annuity West Factory has completed the replacement of the heads of powder injection and raw material workshops at the same time. At present, all the managers in each workshop are relatively young. They are active in thinking, enterprising and innovative. Over the years, the inheritance of Jiangnan Factory has also made the managers at all levels lack the work style of loyalty, unity, truth-seeking and pragmatism, and responsibility, it is believed that they can not only ensure the normal work of the workshop, but also wait for the dispatch of the company's new projects at any time.

2018 We will strengthen safety and environmental protection, strengthen and optimize employment management, do a good job in on-site standardized operation, change staff training methods, and adjust personnel appointment measures. I believe that all employees of Jinxi Factory can work hard under the strong leadership of the company and strive to complete the objectives and tasks of 2018 , adding luster to the 60th anniversary of the group's entrepreneurship and the 20th anniversary of the establishment of the pharmaceutical industry! (according to the speech made by Zheng kunwu, executive deputy director of Jinxi pharmaceutical factory, pharmaceutical company, at the summary commendation meeting of the group company)

More information

The company fully deploys 2018 work

On January 27, the group company held a business analysis meeting to review and summarize the work in 2017, arrange and deploy the work for the new year, and put forward work requirements. At the meeting, various professional companies and directly affiliated enterprises reported on the overall work situation in 2017, focusing on analyzing the existing problems and deficiencies, and proposing corresponding solutions and work plans for 2018. Xiang Chongping, deputy general manager of the group company, systematically combed the current human resources efficiency and human resources development of the company. Chen Tianci, chairman of the board of supervisors, made a report and analysis on the "three reductions and three improvements" and the safety and environmental protection work in 2017. Lan Xiaolong, head of finance, analyzed the risks and challenges currently faced by the company according to the operating data and financial situation of its subordinate enterprises. The functional departments and offices of the headquarters also made a brief report on their annual work. Yu Jianhong, general manager of the group company, made a comprehensive review of the company's operation in 2017, compared and analyzed the main economic indicators of various industrial sectors, and pointed out that looking for new investment and development projects around strategic objectives, promoting the optimization of organizational structure and post setting, significantly improving the level of information management, improving the ability of fund management and tax planning, achieving certain results in scientific and technological innovation and technological transformation, and strengthening marketing management and market expansion, safety and environmental protection work is basically up to standard, training and talent development have achieved new results and other work highlights; at the same time, it summarizes and reflects on the shortcomings in strategic decision-making, management innovation, performance appraisal, market operation, and talent team building. After analyzing the current macroeconomic situation and the future trends of various related industries, Yu Jianhong informed

2020

07-31

Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base

News from our newspaper On January 19, the group company held the second meeting of the tenth board of directors and reviewed and approved the "Proposal on Foreign Investment of Subsidiary Jianfeng Pharmaceutical." On the same day, Jianfeng Pharmaceutical signed an agreement to invest in Shanghai North Carolina Pharmaceutical Technology Co., Ltd. (hereinafter referred to as "Shanghai North Carolina") by acquiring shares and increasing capital. Shanghai Beika is a high-tech enterprise in Shanghai. It has an academician expert workstation and a number of Shanghai high-tech achievements transformation projects. It has won the title of "second prize for scientific and technological progress" in Songjiang District, Shanghai, "patent pilot enterprise" and "enterprise technology center" in Songjiang District, Shanghai. The company has strong research and development capabilities and has obtained 14 patents. At present, its main business is to provide products and customized services for domestic and foreign pharmaceutical companies. The products mainly include Tinib, alkaloids, carbohydrates and other anti-tumor drug intermediates. The customized services are mainly CDMO (contract development and manufacturing) of new drugs and intermediates. Shanghai North Carolina has two wholly-owned subsidiaries, Anhui Changtai Chemical Co., Ltd. (hereinafter referred to as "Changtai Chemical") and Anhui North Carolina Pharmaceutical Co., Ltd. (hereinafter referred to as "Anhui North Carolina"). Changtai Chemical is a pesticide manufacturer designated by the Ministry of Industry and Information Technology. It was established in July 2007. It now has three chemical synthesis workshops and a pesticide preparation compounding workshop, with 10 product approvals and 13 patents. Anhui North Carolina was established in December 2016. Its business scope includes the customization, production and sales of chemical raw materials and pharmaceutical intermediates, and the wholesale and retail of chemical raw materials and products (except hazardous chemicals

2020

07-30

Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base

2020

07-31

Jianfeng Pharmaceutical was rated as a provincial trademark brand demonstration enterprise

On December 28, 2017, Zhejiang Administration for Industry and Commerce announced the list of trademark brand demonstration counties (cities, districts), demonstration towns (streets) and demonstration enterprises in Zhejiang Province in 2017. Jianfeng Pharmaceutical Company was identified as a trademark brand demonstration enterprise, and it was also the only enterprise in Jinhua City to enter the list. Peak Pharmaceutical was established in 1998 and obtained the first registered trademark in 1999. Since then, Jianfeng Pharmaceutical has been actively carrying out brand building in accordance with the requirements of the Trademark Law and other laws and regulations, and has set up an intellectual property department to carry out trademark management, rights protection and other activities; it has established a sound trademark management system, strictly in accordance with the provisions of the Trademark Law to supervise and manage the use of trademarks inside and outside the enterprise, and safeguard the legitimate rights and interests of the enterprise. Establish strategic cooperation with professional institutions, for trademark applications, renewals and other work. In recent years, Jianfeng Pharmaceutical has also explored trademark investment, creating value through intangible assets such as trademarks and brands, promoting efficiency improvement, and further expanding corporate influence; at the same time, it has continuously increased investment in new product research and development and technological transformation, and actively Declare various patents to provide strong support for brand building with technological innovation. According to incomplete statistics, Jianfeng Pharmaceutical and its subsidiaries currently have more than 120 valid trademarks, including 1 well-known trademark in China, 2 well-known trademarks in Zhejiang Province, 5 well-known trademarks in Jinhua City, and 2 overseas registered trademarks; Obtained more than 40 domestic and international patents. Trademark is an important part of intellectual property rights, in the knowledge economy, brand effect is increasingly becoming the leading force of economic development.

2020

07-31

Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base

2020

07-31

The company was rated as an advanced unit of the city's focus on talent and love talent.

News from our newspaper On December 11, the Talent Work Leading Group of the Jinhua Municipal Committee of the Communist Party of China commended the advanced units of Jinhua City that value talents and love talents. 36 units including Jianfeng Group won this honor. The selection of advanced units that value talents and love talents is a measure taken by the Jinhua Municipal Party Committee to further create a good atmosphere of focusing on talents and loving talents, fully respect and make good use of the first resource of talents, serve innovation to drive development, and implement the development strategy of strengthening the province with talents and innovation. The enterprises and institutions that have won this honorary title have always regarded talents as the fundamental driving force for development for a long time, regarded the investment of talents as the most effective investment, and integrated the love of talents into the unit culture. Remarkable achievements have been made in gathering talents, achieving talents, transforming and upgrading, and accelerating development. The Jinhua Municipal Party Committee requires the majority of employers to learn from advanced units, vigorously promote the trend of focusing on talents and loving talents, remove the obstacles to the talent development system and mechanism, and in accordance with the requirements of "walking in the forefront and jointly building Jinhua", in order to promote the construction of a modern metropolitan area and accelerate the construction of the province An important growth pole for high-quality development provides talent support and intellectual guarantee. (this newspaper reporter)

2020

07-31

< 1...38 39 40...61 > 跳转到页